Koch to Market Marrone’s Regalia Biopesticide for Row Crops
2 June 2016 Marrone Bio Innovations said that Koch Agronomic Services, with support from its affiliate, Koch Biological Solutions has secured exclusive rights to sell Regalia Rx in the U.S. and Regalia Maxx in Canada.
Koch will market and sell the products for broad-acre agriculture applications. Regalia Rx and Regalia Maxx improve crop performance by providing defense against fungal pests. Both products also offer significant plant health benefits, Marrone said.
“MBI has a proven history of developing biopesticides that offer effective solutions for growers” said Pam Marrone, founder and CEO of Marrone Bio Innovations. “We believe that Koch’s broad-acre agriculture experience and ability to bring products to market will provide more growers the ability to increase their yields with Regalia Rx and Regalia Maxx on broad-acre row crops.”
Koch Agronomic Services is dedicated to providing fertilizers to increase plant performance that are grounded in science. Koch Agronomic Services has a broad portfolio of enhanced efficiency fertilizer technologies in both the agricultural and turf & ornamental markets including AGROTAIN® nitrogen stabilizer, SUPERU® fertilizer, POLYON® and DURATION® controlled-release fertilizer and UMAXX® stabilized nitrogen among many others.
Koch Biological Solutions has established a strong discovery platform focused on the identification, development and commercialization of biostimulant products that improve plant performance. The company has several promising biological product candidates in various stages of development.
“We’re looking for ways to bring effective, science-based products to the market whether that’s through the development of our own products, or through partnerships with innovators like MBI,” said Bill Boycott, vice president, biologicals and origination for Koch. “Our goal is to provide effective biologicals for our customers and growers. We are very excited about the technology behind Regalia Rx and Regalia Maxx.”
Additional terms of the deal were not disclosed.
Source: Marrone Bio Innovations
Get The Newsletter Today!
